|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:Bayer_Animal_Health
|
|
gptkbp:acquisitionYear
|
2020
|
|
gptkbp:CEO
|
gptkb:Jeffrey_N._Simmons
|
|
gptkbp:divested
|
gptkb:Eli_Lilly_and_Company_(2019)
|
|
gptkbp:focus
|
companion animal health
food animal health
|
|
gptkbp:founded
|
1954
|
|
gptkbp:founder
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:headquartersLocation
|
gptkb:Greenfield,_Indiana,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Elanco Animal Health
|
|
gptkbp:industry
|
animal health
|
|
gptkbp:ISIN
|
US28414H1032
|
|
gptkbp:listedOn
|
gptkb:Fortune_1000
|
|
gptkbp:logo
|
Elanco_logo.svg
|
|
gptkbp:netIncome
|
-$60 million (2022)
|
|
gptkbp:notableProduct
|
gptkb:Comfortis
gptkb:Credelio
gptkb:Galliprant
gptkb:Imrestor
gptkb:Interceptor
gptkb:Osurnia
gptkb:Prevacent
gptkb:Pulmotil
gptkb:Recuvyra
gptkb:Rumensin
gptkb:Trifexis
gptkb:Varenzin-CA1
gptkb:Zelnate
gptkb:Zilmax
gptkb:Zuprevo
gptkb:Advantix
gptkb:Baytril
gptkb:Seresto
Advantage
|
|
gptkbp:numberOfEmployees
|
~9,000
|
|
gptkbp:parentCompany
|
independent (since 2019 IPO)
|
|
gptkbp:products
|
vaccines
feed additives
veterinary pharmaceuticals
|
|
gptkbp:publiclyTraded
|
gptkb:NYSE:_ELAN
|
|
gptkbp:revenue
|
$4.4 billion (2022)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:New_York_Stock_Exchange
gptkb:public_company
|
|
gptkbp:stockSymbol
|
gptkb:ELAN
|
|
gptkbp:website
|
https://www.elanco.com/
|
|
gptkbp:bfsParent
|
gptkb:JAB_Holding_Company
|
|
gptkbp:bfsLayer
|
5
|